Cytosorbents Corporation
NASDAQCytosorbents Corporation filed its Q1 2026 results today — and the stock's 7% single-day drop tells most of the story before you even open the release. Revenue of $8.86 million missed the consensus estimate of $9.36 million. Adjusted EPS of -$0.05 beat the -$0.06 estimate by a penny, but the top-line shortfall dominated the reaction. The miss lands in familiar territory: Germany…
Snapshot as of 28 Jun 2026
Cytosorbents Corporation filed its Q1 2026 results today — and the stock's 7% single-day drop tells most of the story before you even open the release. Revenue of $8.86 million missed the consensus estimate of $9.36…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CTSO — free to start on ORTEX.
Sign up for free →Open CTSO on ORTEX